As of 2024-12-13, the Relative Valuation of Rhythm Pharmaceuticals Inc (RYTM) is (177.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 55.68 USD, the upside of Rhythm Pharmaceuticals Inc based on Relative Valuation is -418.2%.
The range of the Relative Valuation is (181.59) - (199.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.9x - 44.8x | 34.8x |
| Forward P/E multiples | 19.3x - 30.6x | 19.6x |
| Fair Price | (181.59) - (199.31) | (177.17) |
| Upside | -426.1% - -458.0% | -418.2% |
| Date | P/E |
| 2024-12-03 | -9.22 |
| 2024-12-02 | -9.34 |
| 2024-11-29 | -9.52 |
| 2024-11-27 | -9.56 |
| 2024-11-26 | -9.51 |
| 2024-11-25 | -9.20 |
| 2024-11-22 | -9.20 |
| 2024-11-21 | -9.06 |
| 2024-11-20 | -9.11 |
| 2024-11-19 | -9.21 |
| 2024-11-18 | -8.98 |
| 2024-11-15 | -8.63 |
| 2024-11-14 | -9.18 |
| 2024-11-13 | -9.22 |
| 2024-11-12 | -9.84 |
| 2024-11-11 | -10.07 |
| 2024-11-08 | -10.34 |
| 2024-11-07 | -9.81 |
| 2024-11-06 | -9.62 |
| 2024-11-05 | -8.64 |
| 2024-11-04 | -8.14 |
| 2024-11-01 | -7.52 |
| 2024-10-31 | -7.33 |
| 2024-10-30 | -7.61 |
| 2024-10-29 | -7.61 |
| 2024-10-28 | -7.59 |
| 2024-10-25 | -7.45 |
| 2024-10-24 | -7.63 |
| 2024-10-23 | -7.53 |
| 2024-10-22 | -7.54 |
| 2024-10-21 | -7.71 |
| 2024-10-18 | -7.81 |
| 2024-10-17 | -7.83 |
| 2024-10-16 | -8.03 |
| 2024-10-15 | -7.74 |
| 2024-10-14 | -7.71 |
| 2024-10-11 | -7.65 |
| 2024-10-10 | -7.36 |
| 2024-10-09 | -7.33 |
| 2024-10-08 | -7.38 |
| 2024-10-07 | -7.25 |
| 2024-10-04 | -7.62 |
| 2024-10-03 | -7.46 |
| 2024-10-02 | -7.83 |
| 2024-10-01 | -7.95 |
| 2024-09-30 | -8.04 |
| 2024-09-27 | -7.88 |
| 2024-09-26 | -7.85 |
| 2024-09-25 | -8.02 |
| 2024-09-24 | -7.87 |